Therapeutic Strategy Details
| Strategy ID: | S09 |
| Strategy: | cell therapy |
| Other Terms: | high-dose melphalan/autologous peripheral blood stem cell transplantation; Cell therapy; Cell therapy; Anti-inflammatory; Anti-fibrosis; Cell therapy; Anti-fibrosis |
| Related Targets: | B cells; IL-6; IL-1β; TNF-α; TGF-β; EGF; SIRT1 |
| Related Drugs: | chemotherapy; high-dose melphalan; melatonin; granulocyte-colony stimulating factor; metformin; Mesenchymal stem cells; Human gingiva derived MSCs; Streptozotocin; streptozotocin; C-peptide; SIRT1 activators |
| Mechanism: | |
| Reference (PMIDs): | 31301197; 31989677; 32297703; 32312181; 32565049; 32746936; 32798711; 32802201 |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria |
|---|
| Article ID | PMID | Source | Title |
|---|